hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling
Authors:
Open Access
- 14 May 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (10) , 2536-2549
Abstract
Two isoforms of human Polycomb-like protein 3 (hPCL3) have been reported as components of the nuclear Polycomb repressive complex 2 (PRC2), with the short isoform (hPCL3s) showing a dominant cytoplasmic localization. The function of cytoplasmic hPCL3s has, however, not been addressed. In this study, we report that hPCL3s is upregulated in clinical hepatocellular carcinoma (HCC) samples and its expression correlated with HCC clinical features. hPCL3s positively regulated the migration, invasion, and metastasis of HCC cells. hPCL3s interacted with components of the cytoplasmic β-catenin destruction complex, inhibited β-catenin degradation, and activated β-catenin/T-cell factor signaling. Downstream of the β-catenin cascade, IL6 mediated the motility-promoting functions of hPCL3s. Forced expression of hPCL3s in the liver of a HCC mouse model promoted tumorigenesis and metastasis. Taken together, these data show that hPCL3s promotes the metastasis of HCC by activating the β-catenin/IL6 pathway. Significance: hPCL3s has an oncogenic role in hepatocellular carcinoma by activating the β-catenin/IL6 signaling axis to promote metastasis. Cancer Res; 78(10); 2536–49. ©2018 AACR.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81572750)
- National Natural Science Foundation of China (81372289)
- National Natural Science Foundation of China (31520103907)
- National Natural Science Foundation of China (81472282)
- National Natural Science Foundation of China (81602405)
- National Natural Science Foundation of China (81730083)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (1731517600313-14)
- the Chinese Academy of Science (CAS/SAFEA International Partnership Program for Creative Research Teams)
- The Central South University (20170033010007)
This publication has 25 references indexed in Scilit:
- Occupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying PutMolecular Cell, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?Biochemical Pharmacology, 2011
- Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexesBiochemical Journal, 2011
- Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinomaBritish Journal of Cancer, 2010
- Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regenerationMolecular Genetics and Genomics, 2010
- Recruitment ofDrosophilaPolycomb-group proteins by Polycomblike, a component of a novel protein complex in larvaeDevelopment, 2008
- SnapShot: Wnt/β-Catenin SignalingCell, 2007
- Pcl‐PRC2 is needed to generate high levels of H3‐K27 trimethylation at Polycomb target genesThe EMBO Journal, 2007
- Wnt signaling in focal dermal hypoplasiaNature Genetics, 2007